Maravai LifeSciences
MRVI
MRVI
117 hedge funds and large institutions have $2.73B invested in Maravai LifeSciences in 2020 Q4 according to their latest regulatory filings, with 117 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
117
Holders Change
+117
Holders Change %
–
% of All Funds
2.08%
Holding in Top 10
5
Holding in Top 10 Change
+5
Holding in Top 10 Change %
%
% of All Funds
0.09%
New
117
Increased
–
Reduced
–
Closed
–
Calls
$5.22M
Puts
$328K
Net Calls
+$4.89M
Net Calls Change
+$4.89M
Top Buyers
1 |
DCP
D1 Capital Partners
New York
|
+$166M |
2 |
![]()
Fidelity Investments
Boston,
Massachusetts
|
+$160M |
3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$132M |
4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$119M |
5 |
![]()
JPMorgan Chase & Co
New York
|
+$116M |
Top Sellers
No sellers this quarter